Disclosures for "A Case Series of LMNB1-related Adult Onset Autosomal Dominant Adult Leukodystrophy (ADLD)"
-
Dr. Appleberry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Appleberry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Appleberry has received research support from Genentech.